RhumbLine Advisers’s Zymergen Inc. Common Stock ZY Stock Holding History

RhumbLine Advisers’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90,086	Closed	-$260K	–	3322
2022 Q1	$260K	Buy	90,086 +3,902	+5%	+$16.6K	﹤0.01%	2682
2021 Q4	$577K	Buy	86,184 +64,304	+294%	+$624K	﹤0.01%	2455
2021 Q3	$288K	Buy	21,880 +850	+4%	+$18K	﹤0.01%	2786
2021 Q2	$841K	Buy	+21,030	New	+$830K	﹤0.01%	2324

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TVPI

True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DCI

Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSV

Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

RhumbLine Advisers's ZY Position: Q2 2022 in Review

RhumbLine Advisers sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 90,086 shares — an estimated $260K sold.

RhumbLine Advisers first reported a position in ZY in Q2 2021 and held it in 4 quarters. The position peaked at $841K in Q2 2021. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

RhumbLine Advisers reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
RhumbLine Advisers sold 90,086 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $260K.
RhumbLine Advisers first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 4 quarters.
RhumbLine Advisers's Zymergen Inc. Common Stock position peaked at $841K in Q2 2021.
81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.